This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07957/identifier/chemspider/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07957/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07957/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB07957/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07957/identifier/drugbank/

Statements

Subject Item
n2:DB07957
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB07957 n14:DB07957
dcterms:title
METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE
adms:identifier
n8:99444428 n9:ICU n10:446501 n11:393836 n12:DB07957
n5:IUPAC-Name
n6:271B4FF0-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4FF6-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4FF5-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4FF2-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4FF3-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4FF4-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4FEE-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4FEC-363D-11E5-9242-09173F13E4C5 n6:271B4FEF-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4FED-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4FFC-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4FFD-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4FF7-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4FF8-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4FFA-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4FF9-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4FFB-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5002-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5004-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5005-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5001-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5000-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5003-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4FF1-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4FFE-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4FFF-363D-11E5-9242-09173F13E4C5